All posts by: Michael Zand

About Michael Zand

Antibody May Lower Rejection Rates After Stem Cell Transplant in Leukemia Patients – nwitimes.com

Continue reading

2016-01-07

nwitimes.com

Antibody May Lower Rejection Rates After Stem Cell Transplant in Leukemia Patients
nwitimes.com
WEDNESDAY, Jan. 6, 2016 (HealthDay News) — People with acute leukemia who were given antibody therapy before a stem cell transplant fared better than those who didn’t receive the treatment, a small study found. Stem cell transplantation allows doctors …

and more »

Continue reading

2016-01-07

The UCSD Guardian Online

Scientists Use Stem Cells to Model Alzheimer’s Disease
The UCSD Guardian Online
Scientists at UCSD and Harvard University collaborated with international biotech and pharmaceutical companies to develop a stem cell model to study Alzheimer’s disease. This 3-D Matrigel system is more efficient because scientists can test the …

Continue reading

2016-01-06

Antibody May Lower Rejection Rates After Stem Cell Transplant in Leukemia Patients
U.S. News & World Report
WEDNESDAY, Jan. 6, 2016 (HealthDay News) — People with acute leukemia who were given antibody therapy before a stem cell transplant fared better than those who didn’t receive the treatment, a small study found. Stem cell transplantation allows doctors …

and more »

Continue reading

2016-01-06

HealthDay

Antibody May Lower Rejection Rates After Stem Cell Transplant in Leukemia Patients
HealthDay
WEDNESDAY, Jan. 6, 2016 (HealthDay News) — People with acute leukemia who were given antibody therapy before a stem cell transplant fared better than those who didn’t receive the treatment, a small study found. Stem cell transplantation allows doctors …

Continue reading

2016-01-06

San Francisco Business Times (blog)

Stem cell shortcut points S.F. scientists to potential therapy for diabetes
San Francisco Business Times (blog)
Scientists have reprogrammed human skin cells into insulin-producing cells that may offer a new strategy for attacking Type 1 diabetes. The process could take years even to make its way into human clinical trials — let alone a regulator-approved
Insulin-producing pancreatic cells created from human skin cellsEurekAlert (press release)

all 9 news articles »